Почетна › ГRAFT-versus-host болест › Њујорк
Kliničke studije za ГRAFT-versus-host болест u državi Њујорк
12 studija za ГRAFT-versus-host болест traži učesnike na lokacijama u državi Њујорк.
Gradovi u državi Њујорк
Zvanični tekst studije (na engleskom)
PTCy, Bortezomib and Sitagliptin for Prevention of GvHD Following Allogeneic HSCT
- Northwell Health, New Hyde Park
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT07675174A Study of LBP-MARCO and Ruxolitinib in People With Graft-Versus-Host Disease (GVHD)
- Memorial Sloan Kettering Suffolk-Commack (Consent Only), Commack
- Memorial Sloan Kettering Westchester (Consent Only), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- и још 1
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07913672A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant
- Memorial Sloan Kettering Cancer Center @ Commack (Consent only), Commack
- Memorial Sloan Kettering Westchester (Consent only), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- и још 1
Тражи се учесникФаза 2
Узраст 4 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT05675930A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- Mount Sinai Hospital, New York
- Memorial Sloan Kettering, New York
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT06615050Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.
- Roswell Park Comprehensive Cancer Center, Buffalo
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 24. 8. 2026. · NCT06450925Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 7. 7. 2026. · NCT07216443A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
- Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- и још 1
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 7. 7. 2026. · NCT07359859A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant
- Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- New York University (Data Collection Only), New York
- и још 2
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 29. 6. 2026. · NCT07006506Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD)
- Northwell Health, New Hyde Park
Тражи се учесникФаза 1/2
Узраст од 14 до 100 · Оба пола · Ажурирано 29. 5. 2026. · NCT05289167Cord Blood Transplantation in Children and Young Adults With Blood Cancer
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Тражи се учесникФаза 2
До 26 година · Оба пола · Ажурирано 14. 5. 2026. · NCT07566377Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
- University of Rochester, Rochester
Тражи се учесникФаза 2
Узраст 2 и старији · Оба пола · Ажурирано 11. 5. 2026. · NCT04380740Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- Memorial Sloan Kettering Cancer Center, New York
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 15. 4. 2025. · NCT06462365Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.